We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
US-based commercial-stage medical technology company Pulmonx has secured $66m in a financing round led by Ally Bridge Group, a leading global life science investor. New investors including Adage
REMSleep Holdings, Inc. (OTC PINK: RMSL) is proceeding to file for “Emergency Use Authorization” from the FDA for its Deltawave CPAP Interface. The Company is confident the safety
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced a new development and
Israeli medical technology company Itamar Medical has obtained the CE mark approval for its disposable home sleep apnea test (HSAT), dubbed WatchPAT ONE. The CE mark allows commercialisation
Ondine Biomedical, a Canada-based provider of antimicrobial photodisinfection (aPDT) therapies, has secured CE mark approval for its non-antibiotic nasal decolonization therapy. The new Steriwave nasal photodisinfection therapy has
Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today released COVID-19 test performance data demonstrating 100% sensitivity
Advanced Radiology has collaborated with eInformatics to implement the software provider’s Wait In Car application across their Connecticut imaging sites. The application allows the diagnostic imaging group to
Venus Medtech has partnered with medical devices company Opus Medical Therapies to develop, manufacture and market the TMVR and TTVR products in Greater China. The partnership, which covers
FX Solutions has obtained the US Food and Drugs Administration (FDA) 510k approval for its Humeral Cup Stability & Humeral Cup 135/145° Stability for reverse shoulder arthroplasty. The
Roche announced free access to the mySugr Pro app to help the millions of Americans living with diabetes maintain their personalized daily diabetes routine during the COVID-19 crisis.